X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

ADVANCING GENETIC TESTING FOR PROSTATE CANCER

While it is well-recognized that prostate cancer has a significant heritable component, the role of genetics in disease prediction, diagnosis and treatment is gaining increased attention. In his dual role of urologic oncologist and geneticist, Keyan Salari, MD, PhD, urologic surgeon at the Massachusetts General Hospital Department of Urology and urologic oncologist with the Mass General Cancer Center, is exploring the genetic drivers of prostate cancer through a new clinic and extensive research.

Read the full article here. 

source: Massachusetts General Hospital